What is Nasus Pharma Ltd.'s share price today?
Nasus Pharma Ltd. (NSRX) share price today is $3.07 as of November 5, 2026 at 12:20 AM IST. The stock touched a day high of $3.39 and a day low of $3.07.What exchange does Nasus Pharma Ltd. stock trade on, and under what ticker symbol?
Nasus Pharma Ltd. stock trades on AMEX under the ticker symbol NSRX.What is Nasus Pharma Ltd.'s market capitalization?
Nasus Pharma Ltd.'s market capitalization is $37.47M as of November 5, 2026 at 12:20 AM IST.What is Nasus Pharma Ltd.'s price-to-earnings (P/E) ratio?
Nasus Pharma Ltd.'s price-to-earnings (P/E) ratio is N/A as of November 4, 2026.What is Nasus Pharma Ltd.'s price-to-book (P/B) ratio?
Nasus Pharma Ltd.'s price-to-book (P/B) ratio is 3.27 as of November 4, 2026.Can Indian investors buy Nasus Pharma Ltd. shares?
Yes, You can buy Nasus Pharma Ltd. shares from India through Tickertape, via our partnership with ViewTrade IFSC under the IFSCA Global Access framework, subject to RBI’s Liberalised Remittance Scheme (LRS) limits.How can I invest in Nasus Pharma Ltd. shares from India?
Indian investors can buy Nasus Pharma Ltd. shares in three steps: 1. Search Nasus Pharma Ltd. on the Tickertape app and tap Invest. 2. Complete your one-time digital KYC. 3. Fund your account and buy from as low as $1 via fractional shares.How does USD-INR currency movement affect returns from Nasus Pharma Ltd. shares for Indian investors?
Since Nasus Pharma Ltd. trades in USD, an Indian investor's INR returns depend on both the stock's price movement and the USD-INR exchange rate. If the rupee depreciates against the dollar, INR returns are boosted beyond the stock's USD return; if the rupee appreciates, INR returns are reduced.What is the minimum amount required to invest in Nasus Pharma Ltd. shares via Tickertape?
Indian investors can start investing in Nasus Pharma Ltd. (NSRX) shares from as little as $1 through fractional ownership on Tickertape - for example, $10 buys approximately 3.252 shares at the current price of $3.07.
Key Metrics
Key Metrics
Close price divided by the earnings per share for the trailing twelve months
Close price divided by the book value per share at the end of the most recent quarter
Net profit earned per share over the trailing twelve months (sum of the last 4 quarters)
Price-to-Earnings (P/E) ratio divided by the forecasted annual earnings per share (EPS) growth rate over the next five years
Net profit divided by the total revenue for the most recent financial year
Annual dividend per share for the trailing twelve months divided by the close price
Based on consolidated analysts reports
Buy, Sell and Hold recommendations are not available
Price Upside
+415.63%
Earnings Growth
-392.39%
Rev. Growth
—
Company Profile
Company Profile
Forecast
Forecast
Price
Revenue
Earnings
Price Forecast
Price Forecast
All values in $
All values in $
Earnings Per Share Forecast
Earnings Per Share Forecast
All values in $
All values in $
Financials
Financials
Income
Balance Sheet
Cash Flow
| Financial Year | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | Q2 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | - | - | - | - | - | - | - | - | - | - |
| Gross Profit | - | - | - | - | - | - | - | - | - | - |
| Net Income | -0.43 | -0.43 | -0.33 | -0.33 | -0.62 | - | -0.62 | -1.39 | -2.97 | -5.94 |
| Net Profit Margin | - | - | - | - | - | - | - | - | - | - |
Peers
Peers & Comparison
Peers & Comparison
HealthcareDrug Manufacturers - General
Valuation
Returns
Forecast
| Stock | PE TTMPE TTM | PBPB | PEG RatioPEG Ratio |
|---|---|---|---|
| Nasus Pharma Ltd. | - | 3.27 | - |
| Eli Lilly and Company | 46.00 | 31.35 | 1.35 |
| Johnson & Johnson | 41.05 | 8.06 | 3.07 |